Metabolic reprogramming in cancer therapy-related cardiovascular toxicity: Mechanisms and intervention strategies

2025/05/09 by Cheng Zeng, Ying Gao, Bo Lan +2
Biochemistry, Genetics and Molecular Biology · Medicine · #Cancer, Hypoxia, and Metabolism #Chemotherapy-induced cardiotoxicity and mitigation #Metabolism, Diabetes, and Cancer

paper · doi:10.1016/j.semcancer.2025.05.009

openalex publication_date 2025/05/09 · openalex created_date 2025/10/10 · openalex updated_date 2026/07/30

Citations

• Glutamine addiction: a new therapeutic target in cancer
• Fulminant Myocarditis with Combination Immune Checkpoint Blockade
• Cancer treatment and survivorship statistics, 2019
• Hallmarks of Cancer: New Dimensions
• The hallmarks of cancer metabolism: Still emerging
• 2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS)
• The Role of Inflammation in Cardiovascular Disease
• Role of LDH in tumor glycolysis: Regulation of LDHA by small molecules for cancer therapeutics
• 2024 AHA/ACC/ACS/ASNC/HRS/SCA/SCCT/SCMR/SVM Guideline for Perioperative Cardiovascular Management for Noncardiac Surgery: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines